Although there were some binding-assay-specific differences in their KD values and KD(NR4A1)/KD(NR4A2) ratios, each of the DIM-3,5 and DIM8-3,5 analogs bound both receptors and are dual receptor ligands that act as inverse agonists in cancer cell lines. The gene discussed is NR4A2; the disease is cancer.